JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Clinical trial NCT01070836 · COMPLETED

Trial details

NCT number: NCT01070836
Sponsor: Biogen
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis

Start date: 2010-03-01
Primary completion: 2015-11-01
Enrollment: 35895

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.